NCT00419003 Research Study for Major Depressive Disorder: Investigation of Glutamate Medications Status COMPLETED Phase PHASE4
NCT00357045 Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine Status COMPLETED Phase PHASE4
NCT00345098 A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00330174 Acamprosate in Alcoholics With Comorbid Anxiety or Depression Status COMPLETED Phase PHASE4
NCT00300404 Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression Status COMPLETED Phase PHASE3
NCT00296725 Dichotic Listening as a Predictor of Medication Response in Depression Status COMPLETED Phase PHASE1/PHASE2
NCT00296712 Are Two Antidepressants a Good Initial Treatment for Depression? Status COMPLETED Phase PHASE4
NCT00296686 Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression Status TERMINATED Phase PHASE4
NCT00295347 Mineralocorticoid Receptor in the Treatment of Severe Depression Status COMPLETED Phase NA
NCT00291239 Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression Status UNKNOWN Phase PHASE4
NCT00289484 A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression Status UNKNOWN Phase PHASE2
NCT00285766 Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression Status COMPLETED Phase PHASE3
NCT00265291 Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group Status COMPLETED Phase PHASE2